These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16414975)

  • 1. Swedish registers to examine drug safety and clinical issues in RA.
    Askling J; Fored CM; Geborek P; Jacobsson LT; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L
    Ann Rheum Dis; 2006 Jun; 65(6):707-12. PubMed ID: 16414975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register.
    Neovius M; Simard J; Sundström A; Jacobsson L; Geborek P; Saxne T; Feltelius N; Klareskog L; Askling J;
    Ann Rheum Dis; 2011 Mar; 70(3):516-9. PubMed ID: 21081525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis registries in Sweden.
    van Vollenhoven RF; Askling J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S195-200. PubMed ID: 16273807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a family history of RA influence the clinical presentation and treatment response in RA?
    Frisell T; Saevarsdottir S; Askling J
    Ann Rheum Dis; 2016 Jun; 75(6):1120-5. PubMed ID: 26091906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
    Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
    Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics registers in RA: methodological aspects, current role and future applications.
    Nikiphorou E; Buch MH; Hyrich KL
    Nat Rev Rheumatol; 2017 Aug; 13(8):503-510. PubMed ID: 28569267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality register.
    Cagnotto G; Willim M; Nilsson JÅ; Compagno M; Jacobsson LTH; Saevarsdottir S; Turesson C
    Arthritis Res Ther; 2020 Jan; 22(1):15. PubMed ID: 31969172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.
    Ljung L; Askling J; Rantapää-Dahlqvist S; Jacobsson L;
    Arthritis Res Ther; 2014 Jun; 16(3):R127. PubMed ID: 24941916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers.
    Strangfeld A; Hyrich K; Askling J; Arkema E; Davies R; Listing J; Neovius M; Simard J; Symmons D; Watson K; Zink A
    Rheumatology (Oxford); 2011 Jan; 50(1):146-51. PubMed ID: 20861148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charting the possible impact of national guidelines on the management of rheumatoid arthritis.
    Carli C; Bridges JF; Ask J; Lindblad S;
    Scand J Rheumatol; 2008; 37(3):188-93. PubMed ID: 18465453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of biologic DMARDs in RA patients in real life: A systematic literature review and meta-analyses of biologic registers.
    de La Forest Divonne M; Gottenberg JE; Salliot C
    Joint Bone Spine; 2017 Mar; 84(2):133-140. PubMed ID: 27341745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
    Raaschou P; Simard JF; Neovius M; Askling J;
    Arthritis Rheum; 2011 Jul; 63(7):1812-22. PubMed ID: 21305513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register.
    Chatzidionysiou K; Kristensen LE; Eriksson J; Askling J; van Vollenhoven R;
    Scand J Rheumatol; 2015; 44(6):431-7. PubMed ID: 26084325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
    Neovius M; Simard JF; Klareskog L; Askling J;
    Ann Rheum Dis; 2011 Aug; 70(8):1407-14. PubMed ID: 21518724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries.
    Gibofsky A; Palmer WR; Keystone EC; Schiff MH; Feng J; McCroskery P; Baumgartner SW; Markenson JA
    J Rheumatol; 2011 Jan; 38(1):21-8. PubMed ID: 20952478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
    Eriksson JK; Johansson K; Askling J; Neovius M
    Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The safety of biologics : a risk-benefit assessment of treating rheumatoid arthritis with biologics based on registry data on mortality].
    Sander O
    Z Rheumatol; 2010 Nov; 69(9):788-94. PubMed ID: 21063827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register.
    Jiang X; Sandberg ME; Saevarsdottir S; Klareskog L; Alfredsson L; Bengtsson C
    Arthritis Res Ther; 2015 Nov; 17():317. PubMed ID: 26546562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.
    Neovius M; Simard JF; Askling J;
    Ann Rheum Dis; 2011 Apr; 70(4):624-9. PubMed ID: 21149495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?
    Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32669456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.